UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adrenal ablation therapy for unilateral primary aldosteronism: pros and cons

Hypertension research, 2023-03, Vol.46 (3), p.787-789

Shibata, Hirotaka

2023

Volltextzugriff (PDF)

Exosomes and exosomal cargo in urinary extracellular vesicles: novel potential biomarkers for mineralocorticoid-receptor-associated hypertension

Hypertension research, 2021-12, Vol.44 (12), p.1668-1670

Shibata, Hirotaka

2021

Volltextzugriff (PDF)

Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009

Endocrine Journal, 2011, Vol.58(9), pp.711-721

2011

Volltextzugriff (PDF)

Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

Annals of the rheumatic diseases, 2020-05, Vol.79 (5), p.674-675

2020

Volltextzugriff (PDF)

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2016-05, Vol.101 (5), p.1889-1916

2016

Volltextzugriff (PDF)

Visceral fat: a bad companion for mineralocorticoid receptor overactivation

Hypertension research, 2023-05, Vol.46 (5), p.1168-1170

2023

Volltextzugriff (PDF)

Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism

Hypertension research, 2019-06, Vol.42 (6), p.817-824

2019

Volltextzugriff (PDF)

Metabolic Reprogramming Commits Differentiation of Human CD27 + IgD + B Cells to Plasmablasts or CD27 - IgD - Cells

The Journal of immunology (1950), 2017-07, Vol.199 (2), p.425-434

2017

Volltextzugriff (PDF)

Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid

Scientific reports, 2020-10, Vol.10 (1), p.18768-18768, Article 18768

2020

Volltextzugriff (PDF)

Histological classification of Japanese IgA nephropathy with a small number of glomeruli using Bayes’ theorem

Scientific reports, 2023-10, Vol.13 (1), p.18663-18663, Article 18663

2023

Volltextzugriff (PDF)

Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis

Hypertension research, 2022-05, Vol.45 (5), p.887-899

2022

Volltextzugriff (PDF)

Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood

Endocrine Journal, 2022, Vol.69(1), pp.45-54

2022

Volltextzugriff (PDF)

Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism

Hypertension research, 2021-04, Vol.44 (4), p.464-472

2021

Volltextzugriff (PDF)

CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor

Hypertension research, 2021-04, Vol.44 (4), p.407-416

2021

Volltextzugriff (PDF)

Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification

Hypertension research, 2023-01, Vol.46 (1), p.19-31

2023

Volltextzugriff (PDF)

CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity

Hypertension research, 2023-02, Vol.46 (2), p.417-420

2023

Volltextzugriff (PDF)

Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials

Hypertension research, 2022-02, Vol.45 (2), p.210-220

2022

Volltextzugriff (PDF)

Transcription elongation factors DSIF and NELF: Promoter-proximal pausing and beyond

Biochimica et biophysica acta, 2013-01, Vol.1829 (1), p.98-104

2013

Volltextzugriff (PDF)

Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy

Scientific reports, 2020-10, Vol.10 (1), p.18209-18209, Article 18209

2020

Volltextzugriff (PDF)

Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control

Scientific reports, 2021-11, Vol.11 (1), p.21931-21931, Article 21931

2021

Volltextzugriff (PDF)

Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies

Journal of diabetes investigation, 2024-08, Vol.15 (8), p.1075-1083

2024

Volltextzugriff (PDF)

ME-2: MR BLOCKERS AS THE POSSIBLE FIRST-LINE THERAPY IN HYPERTENSION

Journal of hypertension, 2023-01, Vol.41 (Suppl 1), p.e11

Shibata, Hirotaka

2023

Volltextzugriff (PDF)

Adrenocortical Zonation in Humans under Normal and Pathological Conditions

The journal of clinical endocrinology and metabolism, 2010-05, Vol.95 (5), p.2296-2305

2010

Volltextzugriff (PDF)

Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism

The journal of clinical endocrinology and metabolism, 2018-03, Vol.103 (3), p.900-908

2018

Volltextzugriff (PDF)

1 – 25 von 587

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(434)
Mit Volltextzugriff
(485)

Publikationsform

Sprache

Englisch
(520)
Japanisch
(86)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Adrenal ablation therapy for unilateral primary aldosteronism: pros and cons

Exosomes and exosomal cargo in urinary extracellular vesicles: novel potential biomarkers for mineralocorticoid-receptor-associated hypertension

Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009

Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

Visceral fat: a bad companion for mineralocorticoid receptor overactivation

Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism

Metabolic Reprogramming Commits Differentiation of Human CD27 + IgD + B Cells to Plasmablasts or CD27 - IgD - Cells

Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid

Histological classification of Japanese IgA nephropathy with a small number of glomeruli using Bayes’ theorem

Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis

Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood

Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism

CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor

Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification

CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity

Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials

Transcription elongation factors DSIF and NELF: Promoter-proximal pausing and beyond

Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy

Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021

Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control

Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies

ME-2: MR BLOCKERS AS THE POSSIBLE FIRST-LINE THERAPY IN HYPERTENSION

Adrenocortical Zonation in Humans under Normal and Pathological Conditions

Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism

Suchergebnisse filtern